Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Current Pain and Headache Reports
Erschienen in: Current Pain and Headache Reports 2/2016

01.02.2016 | Psychological and Behavioral Aspects of Headache and Pain (D Buse, Section Editor)

Behavioral Weight Loss Treatments for Individuals with Migraine and Obesity

verfasst von: Cynthia Cervoni, Dale S. Bond, Elizabeth K. Seng

Erschienen in: Current Pain and Headache Reports | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Migraine and obesity are each prevalent disorders involving significant personal and societal burden. Epidemiologic research demonstrates a link between migraine and obesity that is further substantiated by putative behavioral, psychosocial, and physiological mechanisms. As obesity is considered a modifiable risk factor for exacerbation of migraine, weight loss may be a particularly useful treatment option for people with comorbid migraine and obesity. Behavioral weight loss interventions complement existing behavioral treatments for migraine and offer patients evidence-based effective strategies for achieving weight loss that could help reduce frequency, severity, and impact of migraine attacks.
Literatur
1.
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, (beta version). Cephalalgia. 2013;33(9):629–808.CrossRef
2.
3.
Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343–9.CrossRefPubMed
4.
Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012;307(5):491–7.CrossRefPubMed
5.
Colditz GW, Wang YC. Economic costs of obesity. In: Hu F, editor. Obesity epidemiology. New York: Oxford University Press, Inc; 2008.
6.
The Obesity Society. Expert panel report: guidelines (2013) for the management of overweight and obesity in adults. Obesity. 2014;22 suppl 2:S41–409.
7.
Peterlin BL, Rosso AL, Rapoport AM, Scher AI. Obesity and migraine: the effect of age, gender and adipose tissue distribution. Headache. 2010;50(1):52–62.PubMedCentralCrossRefPubMed
8.
Munakata J, Hazard E, Serrano D, Klingman D, Rupnow MFT, Tierce J, et al. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) study. Headache: J Head Face Pain. 2009;49:498–508.CrossRef
9.
Blumenfeld AM, Varon SF, Wilcox TK, Buse DC, Kawata AK, Manack, et al. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia. 2011;31:301–15.CrossRefPubMed
10.
Bigal ME, Tsang A, Loder E, et al. Body mass index and episodic headaches: a population-based study. Arch Intern Med. 2007;67:1964–70.CrossRef
11.
Vo M, Ainalem A, Qiu C, Peterlin BL, Aurora SK, Williams MA. Body mass index and adult weight gain among reproductive age women with migraine. Headache: J Head Face Pain. 2011;51(4):559–69.CrossRef
12.
Bigal ME, Liberman JN, Lipton RB. Obesity and migraine: a population study. Neurology. 2006;66:545–50.CrossRefPubMed
13.
Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology. 2006;67:252–7.CrossRefPubMed
14.
Bigal ME, Lipton RB. What predicts the change from episodic to chronic migraine? Curr Opin Neurol. 2009;22:269–76.CrossRefPubMed
15.
Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, Turkel CC, et al. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention study. Headache. 2012;52:1456–70.CrossRefPubMed
16.
Moskowitz MA, Mcfarlane R. Neurovascular and molecular mechanisms in migraine headaches. Cerebrovasc Brain Metab Rev. 1993;5(3):159–77.PubMed
17.
Waeber C, Moskowitz MA. Migraine as an inflammatory disorder. Neurology. 2005;64(10 suppl 2):S9–15.CrossRefPubMed
18.
Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord. 1998;22:1145–58.CrossRefPubMed
19.
Bigal ME, Lipton RB, Hollan PB, Goadsby PJ. Obesity, migraine, and chronic migraine: possible mechanisms of interaction. Neurology. 2007;68:1851–61.CrossRefPubMed
20.
Andress-Rothrock D, King W, Rothrock J. An analysis of migraine triggers in a clinic-based population. Headache. 2010;50:1266–2370.CrossRef
21.
Block JP, He Y, Zaslavsky AM, Ding L, Ayanian JZ. Psychosocial stress and change in weight among US adults. J Epidemiol. 2009;170(2):181–92.CrossRef
22.
Liu H, Umberson D. Gender, stress in childhood and adulthood, and trajectories of change in body mass. Soc Sci Med. 2015;139:61–9.CrossRefPubMed
23.
Tietjen GE, Buse DC, Fanning KM, Serrano D, Reed ML, Lipton RB. Recalled maltreatment, migraine, and tension-type headache: results of the AMPP study. Neurology. 2015;84(2):132–40.PubMedCentralCrossRefPubMed
24.
Tietjen GE, Peterlin BL, Brandes JL, Hafeez F, Hutchinson S, Martin VT, et al. Depression and anxiety: effect on the migraine-obesity relationship. Headache. 2007;47:866–75.CrossRefPubMed
25.
Bond DS, Thomas JG, O’Leary KC, Lipton RB, Peterlin BL, Roth J, Rathier L, Wing RR. Objectively measured physical activity in obese women with and without migraine. Cephalagia, 2014: 1–8.
26.
27.
Scher AI, Lipton RB, Stewart WF. Habitual snoring as a risk factor for chronic daily headache. Neurology. 2003;60:1366–8.CrossRefPubMed
28.
Wober C, Wober-Bingol C. Triggers of migraine and tension-type headache. Handb Clin Neurol. 2010;97:161–72.CrossRefPubMed
29.
Laska MN, Murray DM, Lytle LA, Harnack LJ. Longitudinal associations between key dietary behaviors and weight gain over time: transitions through the adolescent years. Obesity. 2012;20(1):118–25.PubMedCentralCrossRefPubMed
30.
31.
Buchwald H, Avidor Y, Braunwald E, Jensen MD, Porie W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.CrossRefPubMed
32.
Peterlin BL, Calhoun AH, Siegel S, Mathew NT. Rational combination therapy in refractory migraine. Headache. 2008;48:805–19.CrossRefPubMed
33.
Chai NC, Bond DS, Moghekar A, Scher AI, Peterlin BL. Obesity and headache: part II—potential mechanisms and treatment considerations. Headache. 2014;54:459–71.PubMedCentralCrossRefPubMed
34.
Kowacs PA, Piovesan EJ, Tepper SJ. Rejection and acceptance of possible side effects of migraine prophylactic drugs. Headache. 2009;49:1022–7.CrossRefPubMed
35.
Verotti A, Parisi P, Agostinelli S, Loiacono G, Marra F, Coppola G, et al. Weight regain after discontinuation of topiramate treatment in patients with migraine: a prospective observational study. CNS Drugs. 2015;29(2):163–9.CrossRef
36.
Wittgrove AC, Clark GW. Laparoscopic gastric bypass, Roux-en-Y-500 patients: technique and results, with 3–60 month follow-up. Obes Surg. 2000;10(3):233–9.CrossRefPubMed
37.
Christou NV, Sampalis JS, Liberman M, Look D, Auger S, McLean APH, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240(3):416–24.PubMedCentralCrossRefPubMed
38.
Bond DS, Vithiananthan S, Nash JM, Thomas JG, Wing RR. Improvement of migraine headaches in severely obese patients after bariatric surgery. Neurology. 2011;76:1135–8.PubMedCentralCrossRefPubMed
39.
Wadden TA, Butyrn ML, Byrne KJ. Efficacy of lifestyle modification for long-term weight control. Obes Res. 2004;12(S12):151S–62.CrossRefPubMed
40.
NHLBI. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert panel on the identification, evaluation, and treatment of overweight in adults. Am J Clin Nutr. 1998;68:899–917.
41.•
Tsai AG, Felton S, Wadden TA, Hosokawa PW, Hill JO. A randomized clinical trial of a weight loss maintenance intervention in a primary care population. Obesity. 2015;23(10):2015–21. Brief in-person visits with primary care physician can be effective in achieving weight loss. CrossRefPubMed
42.
43.
Wadden TA, Foster GD. Behavioral treatment of obesity. Med Clin North Am. 2000;84(2):441–61.CrossRefPubMed
44.
Johns DJ, Hartmann-Boyce J, Jebb SA, Aveyard P. Diet or exercise interventions vs combined behavioral weight management programs: a review and meta-analysis of direct comparisons. Journ Acad Nutr Diet. 2014;114(10):1557–68.CrossRef
45.••
Verrotti A, Agostinelli S, D’Egidio C, DiFonzo A, Carotenuto M, Parisi P, et al. Impact of a weight loss program on migraine in obese adolescents. Euro J Neurol. 2013;20:394–7. Evidence regarding the use of weight loss intervention in reducing migraine symptoms among adolescents with obesity. CrossRef
46.•
Bond DS, O’Leary KC, Thomas JG, Lipton RG, Papandonatos G, Roth J, et al. Can weight loss improve migraine headaches in obese women? Rationale and design of the Women’s Health and Migraine (WHAM) randomized controlled trial. Contemp Clin Trials. 2013;35:133–44. Future results of this RCT can help clarify role of weight loss in improving migraine in women with obesity. PubMedCentralCrossRefPubMed
47.
Seok JI, Cho HI, Chung SS. From transformed migraine to episodic migraine: reversion factors. Headache. 2006;46:1186–90.CrossRefPubMed
48.
49.
Bond DS, Roth J, Nash JM, Wing RR. Migraine and obesity: epidemiology, possible mechanisms, and the potential role of weight loss treatment. Obese Rev. 2011;12(501):e362–71.CrossRef
50.
51.
Diabetes Prevention Program (DPP) Research Group. The diabetes prevention program (DPP): description of lifestyle intervention. Diabetes Care. 2002;25:2165–71.CrossRef
52.••
Wadden TA, Butyrn ML, Hong PS, Tsai AG. Behavioral treatment of obesity in patients encountered in primary care settings: a systematic review. JAMA. 2014;312(17):1779–91. Supports a range of trained individuals may effectively provide behavioral weight loss interventions, in-person and via telephone, through a primary care setting. PubMedCentralCrossRefPubMed
53.•
Pagoto S, Schneider K, Jojic M, DeBiasse M, Mann D. Evidence-based strategies in weight-loss mobile apps. Am J Prev Med. 2013;45(5):576–82. Including more behavioral strategies in mobile applications for weight loss may increase effectiveness among users with motivational challenges. CrossRefPubMed
54.
Wing RR. Behavioral approaches to the treatment of obesity. In: Bray G, Bouchard C, James PT, editors. Handbook of obesity. New York: Marcel Dekker; 1998. p. 855–73.
55.
Wing RR, Phelan S. Long-term weight loss maintenance. Am J Clin Nutr. 2005;82(1 Suppl):222S–5.PubMed
56.
The Look AHEAD Research Group. The look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity. 2006;14:737–52.PubMedCentralCrossRef
57.
Cooper Z, Fairburn CG. A new cognitive behavioural approach to the treatment of obesity. Behav Res Ther. 2001;39(5):499–511.CrossRefPubMed
58.
DiLillo V, Siegfried NJ, West DS. Incorporating motivational interviewing into behavioral obesity treatment. Clin Psych Rev. 2004;24(3):361–78.CrossRef
59.
Dittrich SM, Gunther V, Franz G, Burtscher M, Holzner B, Kopp M. Aerobic exercise with relaxation: influence on psychological well-being in female migraine patients. Cli J Sport Med. 2008;18(4):363–5.CrossRef
60.
Kelman L. The triggers or precipitants of the acute migraine attack. Cephalagia. 2007;27:394–402.CrossRef
61.
Masheb RM, Lutes LD, Kim HM, Holleman RG, Goodrich DE, Janney CA, et al. Weight loss outcomes in patients with pain. Obesity. 2015;23:1778–84.CrossRefPubMed
62.
Ferarra LA, Pacioni D, Di Fronzo V, Russo BF, Speranza E, Carlino V, et al. Low-lipid diet reduces frequency and severity of acute migraine attacks. Nutr, Metab, Cardiovasc Dis. 2014;25:370–5.CrossRef
63.
Varkey E, Cider A, Carlsson J, Linde M. Exercise as migraine prophylaxis: a randomized study using relaxation and topiramate as controls. Cephalagia. 2011;31(14):1428–38.CrossRef
64.
Varkey E, Cider A, Carlsson J, Linde M. A study to evaluate the feasibility of an aerobic exercise program in patients with migraine. Headache. 2009;49(4):563–70.CrossRefPubMed
65.
Tate DF, Jackvony EH, Wing RR. Effects of Internet behavioral counseling on weight loss in adults at risk for type 2 diabetes: a randomized trial. JAMA. 2003;289:1833–6.CrossRefPubMed
66.
67.
Bond DS, Thomas JG, Raynor HA, Moon J, Sieling J, Trautvetter J, et al. B-Mobile—a smartphone-based intervention to reduce sedentary time in overweight/obese individuals: a within-subjects experimental trial. PLoS One. 2014;9(6), e100821.PubMedCentralCrossRefPubMed
68.
69.
Liu C, Zhu Q, Holroyd KA, Seng EK. Status and trends of mobile-health applications for iOS devices: a developer’s perspective. J Syst Softw. 2011;84:2022–33.CrossRef
Metadaten
Titel
Behavioral Weight Loss Treatments for Individuals with Migraine and Obesity
verfasst von
Cynthia Cervoni
Dale S. Bond
Elizabeth K. Seng
Publikationsdatum
01.02.2016
Verlag
Springer US
Erschienen in
Current Pain and Headache Reports / Ausgabe 2/2016
Print ISSN: 1531-3433
Elektronische ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-016-0540-5

Weitere Artikel der Ausgabe 2/2016

Current Pain and Headache Reports 2/2016 Zur Ausgabe

Childhood and Adolescent Headache (S Evers, Section Editor)

Chronic Migraine in Children and Adolescents

Other Pain (N Vadivelu and A Kaye, Section Editors)

Chronic Daily Headache: Mechanisms and Principles of Management

Secondary Headache (M Robbins, Section Editor)

Headache in Intracranial and Cervical Artery Dissections

Psychological and Behavioral Aspects of Headache and Pain (D Buse, Section Editor)

Model and Processes of Acceptance and Commitment Therapy (ACT) for Chronic Pain Including a Closer Look at the Self

Other Pain (N Vadivelu and A Kaye, Section Editors)

New Labor Pain Treatment Options

Childhood and Adolescent Headache (S Evers, Section Editor)

Lifestyle Factors and Migraine in Childhood

Neu im Fachgebiet AINS

Delir bei kritisch Kranken – Antipsychotika versus Placebo

16.05.2024 Delir Nachrichten

Um die Langzeitfolgen eines Delirs bei kritisch Kranken zu mildern, wird vielerorts auf eine Akuttherapie mit Antipsychotika gesetzt. Eine US-amerikanische Forschungsgruppe äußert jetzt erhebliche Vorbehalte gegen dieses Vorgehen. Denn es gibt neue Daten zum Langzeiteffekt von Haloperidol bzw. Ziprasidon versus Placebo.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren
Bildnachweise